Brad Ringeisen
Executive Director Innovative Genomics Institute
Dr. Bradley Ringeisen is Executive Director of the Innovative Genomics Institute, where he advances gene editing innovations for climate and health. He leads efforts translating CRISPR discoveries into clinical, agricultural, and commercial impact, including the IGI’s “CRISPR for Climate” strategy. Previously, he served as Director of the Biological Technologies Office at DARPA. A pioneer in live cell printing, he holds 14 patents and has authored over 70 publications. He earned his PhD in Physical Chemistry from the University of Wisconsin-Madison.
Seminars
Tuesday 29th September 2026
Advancing CRISPR Genome Editing Tools to Accelerate Clinical Translation
4:00 pm
- Expanding CRISPR editing and delivery capabilities, with broader genomic reach, to unlock treatments for previously undruggable diseases
- Accelerating target discovery and CRISPR therapy optimization using in vitro technologies, robotics, automation, and AI to compress development timelines
- Navigating emerging regulatory pathways, designed specifically for gene therapies, to bring CRISPR treatments to human trials faster
